Infection à HIV

Femme enceinte

• tenofovir disoproxil fumarate (TDF), emtricitabine, and efavirenz.

Prophylaxie post-expositionnelle (PEP)

• Preferred HIV postexposure prophylaxis regimens include tenofovir disoproxil fumarate, emtricitabine, and either dolutegravir or raltegravir and are appropriate whether the exposure was occupational or nonoccupational.

Prophylaxie pré-expositionnelle (PrEP)

• The combination of tenofovir disoproxil fumarate (or tenofovir alafenamide, except in women engaging in receptive vaginal intercourse) plus emtricitabine taken once daily is more than 90% effective, if taken consistently, in preventing HIV acquisition.
• Indications: Data support the use of pre-exposure prophylaxis (PrEP) in specific populations with ongoing high risk for infection, such as sexual partners of infected persons, men who have sex with men, and injection drug users. PrEP is recommended for persons in such groups who can adhere to the daily regimen.

Références

MKSAP 2018